77
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Real-world treatment patterns and opioid use in chronic low back pain patients initiating duloxetine versus standard of care

, , , , &
Pages 825-835 | Published online: 26 Nov 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Carrinna Aviaja Hansen, Martin Thomsen Ernst, Christopher Dyer Smith & Bo Abrahamsen. (2023) Epidemiological Factors Associated with Prescription of Opioids for Chronic Non-Cancer Pain in Adults: A Country-Wide, Registry-Based Study in Denmark Spans 2004–2018. Journal of Pain Research 16, pages 463-485.
Read now

Articles from other publishers (12)

Francesca L. Beaudoin, Rachel Gaither, Weston C. DeLomba & Samuel A. McLean. (2023) Tolerability and efficacy of duloxetine for the prevention of persistent musculoskeletal pain after trauma and injury: a pilot three-group randomized controlled trial. Pain 164:4, pages 855-863.
Crossref
Dermot P. Maher, Chi Heem Wong, Kien Wei Siah & Andrew W. Lo. (2022) Estimates of Probabilities of Successful Development of Pain Medications: An Analysis of Pharmaceutical Clinical Development Programs from 2000 to 2020. Anesthesiology 137:2, pages 243-251.
Crossref
Daltry Dott. 2022. Multidisciplinary Spine Care. Multidisciplinary Spine Care 171 197 .
Dong Huang, Yan-Qing Liu, Ling-Jie Xia, Xian-Guo Liu, Ke Ma, Guang-Zhao Liu, Li-Zu Xiao, Tao Song, Xiao-Qiu Yang, Zhi-Jian Fu & Min Yan. (2021) Expert consensus of Chinese Association for the Study of Pain on the non-opioid analgesics for chronic musculoskeletal pain. World Journal of Clinical Cases 9:9, pages 2068-2076.
Crossref
Jean M. Mitchell & Jack Hadley. (2018) Treatments and Health Outcomes of Medicare Patients With Back Pain. Medical Care Research and Review 77:2, pages 121-130.
Crossref
Carrinna Aviaja Hansen, Martin T. Ernst, Maria Stougaard & Bo Abrahamsen. (2019) Tramadol prescribed use in general and chronic noncancer pain: a nationwide register-based cohort study of all patients above 16 years. Scandinavian Journal of Pain 20:1, pages 109-124.
Crossref
Afsaneh Enteshari-Moghaddam, Ahad Azami, Khatereh Isazadehfar, Hamed Mohebbi, Afshin Habibzadeh & Parinaz Jahanpanah. (2019) Efficacy of duloxetine and gabapentin in pain reduction in patients with knee osteoarthritis. Clinical Rheumatology 38:10, pages 2873-2880.
Crossref
Daniel H Strauss, Divya R Santhanam, Samuel A McLean & Francesca L Beaudoin. (2019) Study protocol for a randomised, double-blind, placebo-controlled clinical trial of duloxetine for the treatment and prevention of musculoskeletal pain: altering the transition from acute to chronic pain (ATTAC pain). BMJ Open 9:3, pages e025002.
Crossref
Laurence L. Miller, Michael D. Leitl, Matthew L. Banks, Bruce E. Blough & S. Stevens Negus. (2015) Effects of the triple monoamine uptake inhibitor amitifadine on pain-related depression of behavior and mesolimbic dopamine release in rats. Pain 156:1, pages 175-184.
Crossref
Erik R. Vanderlip, Mark D. Sullivan, Mark J. Edlund, Bradley C. Martin, John Fortney, Mark Austen, James S. Williams & Teresa Hudson. (2014) National study of discontinuation of long-term opioid therapy among veterans. Pain 155:12, pages 2673-2679.
Crossref
Eva Szigethy, Marc Schwartz & Douglas Drossman. (2014) Narcotic Bowel Syndrome and Opioid-Induced Constipation. Current Gastroenterology Reports 16:10.
Crossref
Douglas Drossman & Eva Szigethy. (2014) The Narcotic Bowel Syndrome: A Recent Update. The American Journal of Gastroenterology Supplements 2:1, pages 22-30.
Crossref